Status:
COMPLETED
Health Outcomes in Rheumatoid Arthritis in Greece
Lead Sponsor:
Pfizer
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
Rheumatoid Arthritis (RA) is a chronic debilitating disease, causing severe pain and progressive joint destruction and leading to partial loss of mobility. The disease has a severe impact on patients'...
Detailed Description
The study will use a prevalence-based approach, recruiting patients at various stages of disease. Subjects will be enrolled sequentially as per their order of appearance at the site, until the maximum...
Eligibility Criteria
Inclusion
- Subjects aged 18 years or older
- Confirmed diagnosis of theumatoid arthritis by investigating physician.
- Evidence of a personally signed and dated informed consent document (or legally acceptable representative).
Exclusion
- Simultaneous participation in an interventional clinical trial.
Key Trial Info
Start Date :
July 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT01001182
Start Date
July 1 2010
End Date
June 1 2012
Last Update
July 28 2014
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Alexandroupoli, Alexandroupoli, Greece, 68100
2
Pfizer Investigational Site
Athens, Athens, Greece, 11527
3
Pfizer Investigational Site
Heraklion, Crete, Greece, 70013
4
Pfizer Investigational Site
Ioannina, Ioannina, Greece, 45332